Characteristic | No. (%) | |||||||
---|---|---|---|---|---|---|---|---|
Total cohort n = 247 377 | Predicted median survival < 3 mo n = 2495 | Predicted median survival 3–6 mo n = 3700 | Predicted median survival 6–12 mo n = 8855 | Predicted mortality risk 20%–33% n = 19 949 | Predicted mortality risk 10%–20% n = 57 935 | Predicted mortality risk 5%–10% n = 86 558 | Predicted mortality risk < 5% n = 67 885 | |
Diseases | ||||||||
Stroke | 39 537 (16.0) | 354 (14.2) | 544 (14.7) | 1345 (15.2) | 3225 (16.2) | 9225 (15.9) | 13 387 (15.5) | 11 457 (16.9) |
Congestive heart failure | 34 562 (14.0) | 994 (39.8) | 1409 (38.1) | 3162 (35.7) | 6011 (30.1) | 11 966 (20.7) | 9123 (10.5) | 1897 (2.8) |
Coronary artery disease | 73 710 (29.8) | 1016 (40.7) | 1563 (42.2) | 3640 (41.1) | 7550 (37.8) | 19 824 (34.2) | 25 264 (29.2) | 14 853 (21.9) |
Alzheimer disease or other dementias | 73 374 (29.7) | 727 (29.1) | 1154 (31.2) | 2824 (31.9) | 6767 (33.9) | 19 608 (33.8) | 27 164 (31.4) | 15 130 (22.3) |
Multiple sclerosis | 3206 (1.3) | 1–5† | 11–15† | 25 (0.3) | 45 (0.2) | 216 (0.4) | 594 (0.7) | 2310 (3.4) |
Parkinson disease | 11 570 (4.7) | 66 (2.6) | 141 (3.8) | 318 (3.6) | 862 (4.3) | 2907 (5.0) | 4234 (4.9) | 3042 (4.5) |
Cancer | 37 139 (15.0) | 1559 (62.5) | 2088 (56.4) | 4180 (47.2) | 6997 (35.1) | 12 557 (21.7) | 8237 (9.5) | 1521 (2.2) |
Chronic obstructive pulmonary disease | 35 964 (14.5) | 733 (29.4) | 1095 (29.6) | 2448 (27.6) | 4687 (23.5) | 10 861 (18.7) | 11 196 (12.9) | 4944 (7.3) |
Prognosis < 6 mo to live | 6429 (2.6) | 1944 (77.9) | 1553 (42.0) | 1409 (15.9) | 911 (4.6) | 495 (0.9) | 110 (0.1) | 7 (0) |
Signs and symptoms of health instability | ||||||||
Vomiting in ≤ 2 of the last 3 d | 1363 (0.6) | 123 (4.9) | 101 (2.7) | 146 (1.6) | 240 (1.2) | 352 (0.6) | 282 (0.3) | 119 (0.2) |
Edema in ≤ 1 of the last 3 d | 83 655 (33.8) | 1098 (44.0) | 1572 (42.5) | 3678 (41.5) | 8213 (41.2) | 21 864 (37.7) | 28 859 (33.3) | 18 371 (27.1) |
Dyspnea | 104 280 (42.2) | 1904 (76.3) | 2614 (70.6) | 5725 (64.7) | 11 946 (59.9) | 29 866 (51.6) | 34 615 (40.0) | 17 610 (25.9) |
Fluid intake < 4 8-oz cups per d (or < 1000 mL/d) in last 3 d | 13 294 (5.4) | 1010 (40.5) | 814 (22.0) | 1453 (16.4) | 2101 (10.5) | 3698 (6.4) | 3057 (3.5) | 1161 (1.7) |
Weight loss of > 5% in the last 30 d or > 10% in the last 180 d | 26 977 (10.9) | 1576 (63.2) | 1808 (48.9) | 3358 (37.9) | 5200 (26.1) | 8367 (14.4) | 5362 (6.2) | 1306 (1.9) |
Decrease in amount of food or fluid usually consumed | 19 349 (7.8) | 1621 (65.0) | 1610 (43.5) | 2803 (31.7) | 3853 (19.3) | 5628 (9.7) | 3142 (3.6) | 692 (1.0) |
Receipt of life-sustaining treatments or therapies | ||||||||
Chemotherapy* | 4988 (2.0) | 247 (9.9) | 325 (8.8) | 654 (7.4) | 998 (5.0) | 1619 (2.8) | 1031 (1.2) | 125 (0.2) |
Dialysis* | 4113 (1.7) | 41 (1.6) | 83 (2.2) | 195 (2.2) | 295 (1.5) | 7053 (12.2) | 1353 (1.6) | 1003 (1.5) |
Oxygen therapy, ventilator, or respirator* | 12 498 (5.1) | 912 (36.5) | 952 (25.7) | 1715 (19.4) | 2572 (12.9) | 3893 (6.7) | 2173 (2.5) | 280 (0.4) |
No. of inpatient admissions over the past 90 d | ||||||||
0 | 160 666 (64.9) | 669 (26.8) | 1070 (28.9) | 2771 (31.3) | 7772 (39.0) | 31 061 (53.6) | 60 362 (69.7) | 56 961 (83.9) |
1 | 72 945 (29.5) | 1247 (50.0) | 1911 (51.6) | 4535 (51.2) | 9542 (47.8) | 22 565 (38.9) | 23 077 (26.7) | 10 068 (14.8) |
2 | 9833 (4.0) | 396 (15.9) | 515 (13.9) | 1099 (12.4) | 1911 (9.6) | 3157 (5.4) | 2186 (2.5) | 569 (0.8) |
≥ 3 | 3933 (1.6) | 183 (7.3) | 204 (5.5) | 450 (5.1) | 724 (3.6) | 1152 (2.0) | 933 (1.1) | 287 (0.4) |
No. of emergency department visits over past 90 d | ||||||||
0 | 186 159 (75.3) | 1432 (57.4) | 2231 (60.3) | 5345 (60.4) | 12 907 (64.7) | 40 722 (70.3) | 66 442 (76.8) | 57 080 (84.1) |
1 | 44 096 (17.8) | 635 (25.5) | 869 (23.5) | 2140 (24.2) | 4630 (23.2) | 11 951 (20.6) | 15 165 (17.5) | 8706 (12.8) |
2 | 10 725 (4.3) | 249 (10.0) | 341 (9.2) | 806 (9.1) | 1463 (7.3) | 3308 (5.7) | 3214 (3.7) | 1344 (2.0) |
≥ 3 | 6397 (2.6) | 179 (7.2) | 259 (7.0) | 564 (6.4) | 949 (4.8) | 1954 (3.4) | 1737 (2.0) | 755 (1.1) |